- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02346149
Effect of Acute Hyperglycemia on Renal Tissue Oxygenation (Glucox)
Effect of Acute Hyperglycemia on Renal Tissue Oxygenation as Measured By BOLD-MRI in Individuals With Impaired Glucose Tolerance and Controls
Diabetes Mellitus (DM) includes several metabolic diseases all characterized by high sugar levels in the blood. Although diabetic nephropathy is widespread, its underlying pathophysiological mechanisms remain poorly understood and, so far, little progress has been made to prevent the development of diabetic nephropathy and to delay kidney functions decline.
Increasing amount of data based on animal studies support the pathogenic role of tissue hypoxia in the development and progression of diabetic nephropathy. Blood Oxygenation-Level Dependent Magnetic Resonance Imaging (BOLD-MRI) is increasingly used in research to measure cortical and medullary oxygenation in a non-invasive manner. Interestingly, in two cross-sectional clinical studies, we have recently found a positive correlation between high circulating blood glucose levels and cortical R2* levels in type 2 DM patients. This discovery suggests that an increase in glycemia might acutely decrease renal tissue oxygenation.
The goal of this study is to investigate the impact of serum glucose on renal tissue oxygenation in healthy subjects and subjects with glucose intolerance.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Therefore, we plan to recruit 10 healthy subjects and 10 glucose intolerant patients with preserved kidney functions and to perform repetitive BOLD-MRI, before and after the administration of IV glucose. This will allow us to study the influence of hyperglycemia as a single factor, regardless of inflammation, oxidative stress and medical treatments, such as oral hypoglycemic agents and/or insulin, which are confounding factors present in all DM patients.
The main hypothesis of the project is that acute hyperglycemia could be partially responsible for renal tissue hypoxia detected in diabetic nephropathy cases.
In this study we will include 60 participants with a family history of diabetes, with a Body Mass Index (BMI) over 25 kg / m2 and/or having glucose intolerance. Each participant will undergo an initial glucose tolerance test. In total, we will select 10 participants with impaired glucose tolerance and 10 healthy subjects (matched for sex and age), to be included as control group.
Selected subjects will return for a third visit at CHUV (V3): they will start at home with an oral hydration protocol (load dose of 3 ml / kg at 8:00 am, followed by 1 ml / kg every hour between 9:00 am and 3:00 pm to avoid as much as possible changes in kidney perfusion). Patients will arrive at the Department of Nephrology and Hypertension (CHUV) at 11.00 am. In this occasion, two catheters will be placed into each patient's arm. Later, participants will be escorted to the Radiology Department to undergo four renal oxygenation imaging (between 1:00 pm and 2:00 pm) by the mean of BOLD-MRI technique. During this period, patients and control subjects will lie down and are not allowed to stand up. At T0, they will receive a bolus (0.75 ml / kg) of glucose 20%. Subsequently, four BOLD-MRI scans, together with blood tests, will be performed at T0, T1 (+10 min), T2 (+20 min), T3 (+30 min). Sodium intake will be measured by 24 hours urinary collection the day before V3 (sodium is known to influence R2*).
Studietype
Inschrijving (Werkelijk)
Fase
- Vroege fase 1
Contacten en locaties
Studie Locaties
-
-
Vaud
-
Lausanne, Vaud, Zwitserland, 1011
- Department of Nephrology, Centre Hospitalier Universitaire Vaudois
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Positive family history of diabetes
- BMI > 25 kg / m2
- eGFR > 60 ml / min / 1.73 m2
- Understanding and signing the informed consent
Exclusion Criteria:
- Documented cardiac disease
- Documented liver failure
- Renal malformations, kidney diseases or documented renal artery stenosis
- History of organ transplantation
- Significant comorbidities compromising life expectancy
- Anemia
- Type 1 or 2 diabetes
- Psychiatric illness
- Contraindication to MRI
- Pregnancy or breastfeeding
- Chronic drug intake such as antihypertensive (except for beta blockers and calcium antagonists), non steroidal anti-inflammatory drugs, diuretics or oral antidiabetics
- Blood donation 2 months before the MRI investigation day
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Ander: Patient with impaired glucose tolerance
Bold-MRI before and after glucose injection
|
Intravenous infusion (0.75 ml / kg) over 1 min
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
Cortical and medullary renal R2* MRI signal variation, before, during and after an induced hyperglycemic state
Tijdsspanne: Four R2* imaging will be performed during an investigation day between 1:00 pm and 2:00 pm
|
Four R2* imaging will be performed during an investigation day between 1:00 pm and 2:00 pm
|
Intergroup variability of MRI R2* signal, before, during and after an induced hyperglycemic state
Tijdsspanne: Four R2* imaging will be performed during an investigation day between 1:00 pm and 2:00 pm
|
Four R2* imaging will be performed during an investigation day between 1:00 pm and 2:00 pm
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Michel Burnier, MD, Centre Hospitalier Universitaire Vaudois
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- SNSF132913
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op glucose 20%
-
University of OuluOulu University HospitalVoltooidHyponatriëmie | Uitdroging | Hypokaliëmie | HypernatriëmieFinland
-
Region Örebro CountyWervingMechanische ventilatie | Atelectase | Verdeling van ventilatieZweden
-
RIVAGESNog niet aan het wervenChronische ziekte | Medicatienaleving | Polypathologie | Bejaarde | Digitale applicatie
-
Aspire Health ScienceOnbekendCOVID-19 Longontsteking
-
University Hospitals Cleveland Medical CenterIngetrokken
-
Assistance Publique - Hôpitaux de ParisVoltooidHypoxie | Onvruchtbaarheid | Embryo-cultuur
-
Azienda Socio Sanitaria Territoriale degli Spedali...VoltooidTranscraniële magnetische stimulatie | Neuronale plasticiteit | Elektromagnetische velden
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinWervingAcute lymfatische leukemie | Acute lymfoblastische leukemie, pediatrisch | Acute lymfoblastische leukemie, bij terugval | Acute lymfoblastische leukemie terugkerend | Acute lymfoblastische leukemie met mislukte remissie | Acute lymfoblastische leukemie heeft geen remissie bereiktVerenigde Staten
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinVoltooidLymfoom, B-cel | Lymfoom, non-Hodgkin | Chronische lymfatische leukemie | Klein lymfocytisch lymfoomVerenigde Staten
-
South China Center For Innovative PharmaceuticalsXiangya Hospital of Central South UniversityVoltooid